Board allots 11,50,000 equity shares on conversion of warrants at Rs. 63.80 each
Board on 30-09-2026 approved allotment of 11,50,000 equity shares of Rs. 10 each on conversion of warrants.
- Shares Allotted
- 11,50,000 equity shares of Rs. 10 each
- Warrant Conversion Price
- Rs. 63.80 per warrant; Rs. 47.85 per warrant (75% of issue price) received
- Capital Inflow
- Rs. 5,50,27,500
- Paid-up Capital After Allotment
- 31,874,303 shares (Rs. 318,743,030)
- Outstanding Warrants
- 14,80,000 warrants remaining for conversion
What happened
The Board of Directors met on 30-09-2026 (11.30 AM to 12.30 PM) and approved the allotment of 11,50,000 equity shares of face value Rs. 10 each, arising from conversion of fully convertible warrants issued earlier on a preferential basis.
Money received
- Warrants were issued at Rs. 63.80 per warrant (premium of Rs. 53.80), priced under Chapter V of SEBI ICDR Regulations.
- On conversion the company received Rs. 47.85 per warrant, being 75% of the issue price.
- Total inflow for this tranche: Rs. 5,50,27,500.
Capital structure
- Before the earlier allotment: 28354303 shares (Rs. 283543030).
- After the 06-08-2026 allotment: 30724303 shares (Rs. 307243030).
- After this 30-09-2026 allotment: 31874303 shares (Rs. 318743030).
Warrant status
- Total warrants allotted on 23-05-2025: 50,00,000.
- Converted on 06-08-2026: 23,70,000.
- Converted on 30-09-2026: 11,50,000.
- Still outstanding for conversion within 18 months from 23-05-2025: 14,80,000.
Who received shares
The allotment covers both promoter and non-promoter (public) category holders. In this tranche, Nimit Rajesh Ghatalia (Promoter & Promoter Group) converted 150000 warrants, taking his holding to 1650000 shares (5.18%). Public allottees include Archana Pramod Wani with 200000 shares (0.63%), Priti Vijaykumar Shah with 500000 shares (1.57%), Vaishali Aggarwal with 250000 shares (0.78%), Sujata Tushar Mehta with 25000 shares (0.08%) and Tushar Mehta HUF with 25000 shares (0.08%).
How to read it
Conversion of warrants brings fresh funds into the company but also increases the number of shares outstanding, which spreads earnings over a larger share base. Existing promoter percentages shift slightly as the base expands, for example Bina Rajesh Ghatalia moves from 14.66% to 14.13% without converting any warrants in this tranche. With 14,80,000 warrants still outstanding, further share issuance is possible within the conversion window.
Also from Aarey Drugs & Pharmaceuticals
Revised outcome: Board approves allotment of 11,50,000 equity shares on warrant conversion
7 Oct 2026
Aarey Drugs & Pharmaceuticals Ltd promoter buys 7.71% stake
5 Oct 2026
Aarey Drugs & Pharmaceuticals Ltd shareholder buys 0.47% stake, holding rises to 5.18%
5 Oct 2026
More numbers
- Equity shares allotted on conversion11,50,000 Equity Shares
- Face value per shareRs. 10/- each
- Warrant issue priceRs. 63.80/- Each
- Amount received per warrant on conversionRs. 47.85/- per warrant
- Share of issue price received75%
- Total amount received in this trancheRs. 5,50,27,500/-
- Total warrants allotted50,00,000 Convertible Warrants
- Warrants converted on 06-08-202623,70,000
- Warrants outstanding for conversion14,80,000
- Paid-up shares after 06-08-2026 allotment30724303
- Paid-up shares after 30-09-2026 allotment31874303
- Paid-up capital after allotmentRs. 318743030/-
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.